CAC Software vs EchoGo Amyloidosis
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A focuses on quantifying coronary artery calcification from CT scans to assess coronary artery disease risk, while Tool B aids in the early detection of cardiac amyloidosis through echocardiogram analysis. Although both are AI-powered cardiology tools, they address distinct cardiac conditions and utilize different imaging modalities, making them suitable for different diagnostic pathways.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Imbio's Coronary Artery Calcification (CAC) software is designed to help radiologists and cardiologists determine and quantify calcification within the coronary arteries, supporting risk assessment for coronary artery disease. Ultromics' EchoGo Amyloidosis is an AI-powered screening tool for the early detection of cardiac amyloidosis from echocardiogram video clips.
Imbio's CAC software analyzes non-contrast chest computed tomography (CT) scans to identify and quantify coronary artery calcification. Ultromics' EchoGo Amyloidosis requires echocardiogram video clips for its AI-powered screening for cardiac amyloidosis.
Imbio's CAC software outputs include the Agatston score, arterial age, calcified lesion mass and volume, along with 3D visualizations and annotated images. Ultromics' EchoGo Amyloidosis provides a diagnostic output indicating whether a patient's echocardiogram is 'suggestive' or 'not suggestive' of cardiac amyloidosis, based on the analysis of echocardiographic markers.
For Ultromics' EchoGo Amyloidosis, specific reimbursement codes are available, including an NTAP Code for inpatient analysis (Medicare-covered) and a HCPCS Code for outpatient analysis (covered by Medicare and select commercial insurers). Imbio's CAC software requires contacting the company directly for pricing information, and specific reimbursement codes are not detailed.
Imbio's CAC software is designed to assist both radiologists and cardiologists in their assessment of coronary artery calcification. Ultromics' EchoGo Amyloidosis is primarily aimed at cardiologists for the early detection of cardiac amyloidosis.